celastrol has been researched along with thiazolyl blue in 1 studies
Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (thiazolyl blue) | Trials (thiazolyl blue) | Recent Studies (post-2010) (thiazolyl blue) |
---|---|---|---|---|---|
885 | 1 | 741 | 4,625 | 20 | 1,230 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goh, JN; Kannaiyan, R; Khin, E; Kumar, AP; Li, F; Luk, JM; Rajendran, P; Sethi, G; Shanmugam, MK; Tergaonkar, V; Wang, W; Wong, KF | 1 |
1 other study(ies) available for celastrol and thiazolyl blue
Article | Year |
---|---|
Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Female; Gene Expression Regulation; Humans; In Vitro Techniques; Janus Kinase 2; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pentacyclic Triterpenes; Signal Transduction; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles; Triterpenes; Vanadates | 2012 |